A Conference focusing on Foods for Specific Groups (FSG) was held in Palace Stefania, Budapest on Thursday the 16th of November. The event, hosted by HUDSA, considered the new legal environment and consequences for FSG in Hungary. The conference was attended by 230 representatives from a range of SMEs, authorities and pharma companies.
Dr István Bérci, President of HUDSA welcomed attendees and provided the opening address. He acknowledged the importance of addressing the changing legislation and the impact that it would have for a variety of stakeholders currently operating within the FSG Hungarian market. Deputy Director General, Zoltan CSerhati MD, followed with an overview of the National Institute of Pharmacy and Nutrition (NIPN), the licensing authority for pharmaceutical and public administrational matters in Hungary. The Head of the Department, Dr Eva Barna then discussed the legal issues and news surrounding FSGs and put forward some practical suggestions for moving forward in the area.
A short break allowed for attendees to discuss the matter informally before returning for a discussion from the EPHM Director General, Mr Patrick Ahern. The focus of the discussion, transitioning from PARNUTS to FSG, considered the current legislation and how this applied to the Hungarian market. The presentation rose a number of questions and generated a lot of discussion. Dr Adam Foldvari, Marketing Director at Walmark in Hungary, then continued by considering the key issues affecting FSG in Hungary from an economic perspective. Again, this discussion was well received by attendees.
The final session after lunch consisted of two speakers. The first, Dr Ildiko Fazekas, Secretary General for the Hungarian Self-regulatory Board, shared his experiences in relation to advertising FSG. The talk provided interesting examples and insights that were relevant to all participants at the conference. The final discussion of the conference was given by Judit Barkanyi from Beres. Dr Barkanyi provided a detailed discussion on the background of pharmaceutical technology for FSG and allowed the attendees to consider details that were necessary and pertinent.
The speakers at the conference provided realistic and practical considerations for those operating with the FSG category in Hungary. The presentation provided by EPHM Director General, Mr Patrick Ahern can be downloaded below. Presentations from the other speakers and photographs from the conference are also available through the HUDSA website by clicking here.
Information about 'cookies': according to the EU Privacy and Electronic Communications Regulations in force, we are required to obtain your consent to use 'cookies' that help us understand how you use this website. If you continue browsing this site we understand that you are giving us your consent.